Supreme Resources LTD Announces Closing of Financing

SEPTEMBER 30, 2014 SUPREME RESOURCES LTD. (“Supreme” or the “Corporation”) (TSX-V: “SPR”) announces that the Company has closed its previously announced non-brokered private placement. 79,900,000 Common Share Units at $0.005 per unit were issued for total gross proceeds of $399,500. Each Unit consists of one common share and one common share purchase warrant. Each warrant is exercisable for […]

Supreme Appoints Chris Bechtel to Advisory Board

SEPTEMBER 23, 2014 September 23rd, 2014, Vancouver, BC – Supreme Pharmaceuticals Inc. (the “Company”) (SPRWF – OTC) (“SL” – CSE)is pleased to announce the appointment of Chris Bechtel to its advisory board. Mr. Bechtel brings a wealth of experience in capital markets, start-ups, and medicinal marijuana to the Company. Mr. Bechtel launched a small business […]

Supreme Completes First Tranche of Previously Announced Private Placement

SEPTEMBER 22, 2014 September 22, 2014, Vancouver, BC – Supreme Pharmaceuticals Inc. (“Supreme” or the “Company“) (SL:CSE) is pleased to announce that it has closed the first tranche of its previously announced unit financing (see news releases dated August 15th and September 4, 2014) for total gross proceeds of $2,239,232.50 (the “Financing“). At closing, Supreme issued […]

Supreme Retains Capital Markets Advisor

SEPTEMBER 18, 2014 September 18th, 2014, Vancouver, BC – Supreme Pharmaceuticals Inc. (the “Company”) (“SL” – CSE) is pleased to announce that it has engaged Merriman Capital, Inc. (“Merriman”), a wholly owned subsidiary of Merriman Holdings, Inc. (OTCQX:MERR) as its Capital Markets Advisor. As part of the engagement, Merriman will act as Principal American Liaison (PAL) […]

Supreme Provides Construction Update

SEPTEMBER 16, 2014   September 16th, 2014, Vancouver, BC – Supreme Pharmaceuticals Inc. (the “Company”) (SPRWF – OTC) (“SL” – CSE) is pleased to report that it has made significant progress regarding the construction and required security implementation at its 342,000 square foot greenhouse facility located in Kincardine, Ontario (the “Greenhouse”). Backed by strong support from […]

Supreme Updates Financing and Announces Launch of New Website

SEPTEMBER 03, 2014   September 3rd, 2014, Vancouver, BC – Supreme Pharmaceuticals Inc. (the “Company”) (“SL” – CSE) wishes to announce its intention to offer securities under the previously announcednon-brokered private placement (see news release dated August 15th, 2014) of up to 20 million units in the capital of the corporation (“Units”) at a price of $0.25 […]

Supreme Pharmaceuticals Inc. Announces Financing

AUGUST 15, 2014   August 15, 2014, Vancouver, BC – Supreme Pharmaceuticals Inc. (“Supreme” or the “Company”) (SPRWD – OTC)  (“SL” – CSE)is pleased to announce that it is undertaking a non-brokered private placement of up to 20 million units in the capital of the Corporation ( “Units”) at a price of $0.25 per Unit for aggregate gross proceeds […]

Share to Trade on a Consolidated Basis on July 31 2014

JULY 28, 2014   July 28, 2014, Vancouver, BC – Supreme Pharmaceuticals Inc. (the “Company”) (SPRWD – OTC) (“SL” – CSE) is pleased to report that in respect to its previously announced intention to consolidate its issued and outstanding share capital on the basis of five (5) current shares for one (1) new share, its shares […]

Supreme to Evaluate US Opportunities and Provides Update

JULY 22, 2014   July 22nd, 2014, Vancouver, BC – Supreme Pharmaceuticals Inc. (the “Company”) (SPRWD– OTC) (“SL” – CSE) is pleased to report that through the company’s newly formed subsidiary, Supreme Pharmaceuticals USA Inc., it is in the preliminary stages of evaluating medical cannabis investment opportunities within the State of Arizona, in the US. These […]

Supreme Pharmaceuticals Inc. Completes Shares for Debt Transaction

JULY 22, 2014 July 22, 2014, Vancouver, BC – Supreme Pharmaceuticals Inc. (“Supreme” or the “Company”) (SPRWD – OTC) (“SL” – CSE) announced that it has entered into Settlement Agreements with two creditors to settle debts owing to them by the issuance of a total of 652,500 common shares at a deemed issue price of $0.07 […]